phive2015 JP Morgan raised its rating of Glaukos (NYSE:GKOS) to overweight, citing the company’s recently approved ophthalmology product iDose. The…
Read More »Glaukos
FG Trade/E+ via Getty Images Truist has initiated coverage of Glaukos (NYSE:GKOS) with a buy rating, citing the company’s glaucoma…
Read More »